Carl Zeiss Meditec (OTCMKTS:CZMWY) Stock Price Down 1% – Time to Sell?

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) fell 1% during trading on Thursday. The company traded as low as $34.88 and last traded at $34.9950. 2,659 shares traded hands during trading, a decline of 20% from the average session volume of 3,322 shares. The stock had previously closed at $35.35.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Morgan Stanley began coverage on Carl Zeiss Meditec in a research note on Wednesday, September 2nd. They set an “underweight” rating on the stock. Zacks Research cut shares of Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 11th. Finally, UBS Group downgraded shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research report on Tuesday, August 11th. Two analysts have rated the stock with a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, Carl Zeiss Meditec currently has a consensus rating of “Strong Sell”.

Carl Zeiss Meditec Trading Down 1.0%

The company has a fifty day moving average of $35.55 and a 200-day moving average of $32.24.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a Germany-based medical technology company focused on ophthalmology and microsurgery. The company develops, manufactures and distributes diagnostic and therapeutic systems, surgical equipment, implants and related digital solutions for healthcare professionals.

Its ophthalmic portfolio includes devices for eye examinations and diagnostics, laser systems for refractive and cataract procedures, surgical microscopes, intraocular lenses and other products used in cataract, retinal, glaucoma and corneal treatments.